Long Covid is likely a disease with many subtypes that may have different risk factors (genetic, environmental, etc.) and distinct biologic mechanisms that may respond differently to treatments.
Mechanisms of Long Covid include viral persistence, dysregulated immune response, mitochondrial dysfunction, vascular (endothelial) and/or neuronal inflammation and microbiome dysbiosis
b. The attribution of #LongCovid symptoms to psychological causes has no scientific support; it perpetuates stigma and disenfranchises patients from accessing the care they need.
c. The lack of consensus on terms, definitions, and clinical trial end points for Long Covid is slowing progress and hampering industry engagement in clinical trials.
Building consensus on these parameters is urgently needed.
➡️masking — especially in high risk places
➡️improved air quality through filtration and ventilation
➡️Updating building codes to require mitigation against airborne pathogens
Governments and funding agencies should support a comprehensive portfolio of research in infection-associated chronic illnesses
Although SARS-CoV-2 can cause chronic disease, it is not alone. Influenza virus, Epstein-Barr virus, Ebola virus, polio virus, and many others also have long-term health effects.
Myalgic encephalomyelitis/chronic fatigue syndrome is also triggered by infection.
Research in this area has been disproportionately underfunded relative to the burden of long-term disability and disease caused by infections.
LongCovid does not only affect patients and their life expectancy, but also societal wellbeing and economic indicators (labour participation and economic productivity).
Preventing long COVID should be a public and a global health priority.
The 60% higher risk of death in people hospitalized for C vs flu should be interpreted in the context of 2-3 times more hospitalization for C than hospitalization for flu